New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile

发布时间：2014-05-13 / 浏览次数：639 次

上一篇： Selection and characterization of Staphylococcus aureus mutants with reduced susceptibility to the investigational oxazolidinone MRX-I

下一篇： Metabolism of MRX-I, a novel antibacterial oxazolidinone, in humans: the oxidative ring opening of 2,3-dihydropyridin-4-one catalyzed by non-P450 enzymes

返回列表